We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Shimadzu and Phenomenome Discoveries Announce Exclusive Collaboration
News

Shimadzu and Phenomenome Discoveries Announce Exclusive Collaboration

Shimadzu and Phenomenome Discoveries Announce Exclusive Collaboration
News

Shimadzu and Phenomenome Discoveries Announce Exclusive Collaboration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Shimadzu and Phenomenome Discoveries Announce Exclusive Collaboration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Shimadzu Corporation and Phenomenome Discoveries Inc (PDI) have agreed to integrate high mass accuracy mass spectrometry data generated on Shimadzu Corporation's LCMS-IT-TOF systems with the Phenomenome Profiler™ informatics platform.

This announcement further combines the Shimadzu Corporation's mass spectrometry product line with PDI's software tools to visualize and interpret data for biomarker discovery and global profiling studies including comparative proteomic studies.

Kozo Shimazu, Corporate Officer, Deputy General manager For Mass Spectrometry, at Shimadzu Corporation, stated, “Our collaboration with PDI has been enhanced to take into account the growing need of researchers working in biomarker discovery and comparative proteomics studies to use high mass accuracy MSn data.”

Mr. Shimazu added, “We believe that this collaboration further strengthens the relationship between Shimadzu Corporation and PDI and helps deliver a unique and integrated solution to help find components of biologically significance.”

John Hyshka, COO of Phenomenome Discoveries, said “Our agreement with Shimadzu Corporation allows investigators working in global profiling to find and identify key markers for disease using innovative mass spectrometry technology. This agreement reflects our growing commitment to develop new tools for advancing research into working with large data sets to identify key markers for disease.”

Advertisement